BioSpace News Archive

By Region, Asia Pacific Is Expected To Be A Lucrative Region For Medical Bed Suppliers Driven By Developing Healthcare Infrastructure In Various Emerging Economies

At Medivir’s AGM on May 5, Uli Hacksell, Lennart Hansson, Bengt Westermark and Yilmaz Mahshid were re-elected and Anette Lindqvist was newly elected as board members in the company. Uli Hacksell was re-elected as chairman of the board. An van Es Johansson had declined re-election.

Skanska and the Kronoberg Region have signed an agreement on phase one of the work on Växjö’s new emergency hospital.

Wilmington, Delaware, United States, Transparency Market Research Inc. – Products and tools in the global ophthalmic drug delivery devices market are aimed at treating various ophthalmic disease conditions that can affect various parts of the human eye and ocular systems.

Immuron Limited announced that it has deprioritized SARS-CoV-2 research to focus on the clinical development of our more advanced stage therapeutic drug candidates.

IASO Biotherapeutics announced that the Center for Drug Evaluation of China’s National Medical Products Administration approved its investigational new drug application for the new extended indication of Neuromyelitis Optica Spectrum Disorder for a fully human BCMA chimeric antigen receptor autologous T cell Injection.

Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2022 fourth quarter and full year on Wednesday, August 24, 2022, after the market closes.

Ginkgo Bioworks today announced the purchase of certain epidemiological data infrastructure assets from Baktus, Inc.

Palatin Technologies, Inc. today announced that it intends to effect a 1-for-25 reverse split of its issued and outstanding common stock (the “Reverse Stock Split”).

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Lauren Sabella, Chief Operating Officer, will resign from the Company effective September 30, 2022.